Literature DB >> 17205279

Determining mucosal barrier injury to the oesophagus using CT scan.

N M A Blijlevens1, J P Donnelly, D Yakar, C E van Die, T de Witte.   

Abstract

INTRODUCTION: Oral mucositis is recognised as one of the most debilitating complications of high-dose cytostatic chemotherapy used to prepare for haematopoietic stem cell transplantation (HSCT), but very little is known about oesophageal mucositis, as endoscopy is not routinely performed.
MATERIALS AND METHODS: We incorporate the computed tomography (CT) scan in the diagnostic workup of fever during neutropenia to detect evidence of pulmonary complications. This allowed us to evaluate whether mucosal barrier injury to the oesophagus can be determined. We selected 46 patients without oesophageal cancer or immune suppression (controls), who had a normal oesophagus, and measured the mucosal thickness at the upper part (UP), middle part (MP) and lower part (LP) of the oesophagus. Next, we selected 30 patients having a CT scan done for diagnostic purposes within 14 days after HSCT and measured mucosal thickness at the same levels. We also scored oral mucositis and gut toxicity.
RESULTS: The mucosal thickness of the UP, MP and LP, respectively, for the controls (mean +/- SD) was 4.1 mm (+/-1.1), 4.2 mm (+/-1.2) and 4.8 mm (+/-1.3), and the corresponding values for the subjects were 5.9 mm (+/-2.2), 5.9 mm (+/-2.0) and 7.7 mm (+/-3.0). Analysis of variance showed statistically significant differences between subjects and controls at all oesophageal levels. All patients suffered from severe oral mucositis at the time.
CONCLUSION: Hence, mucosal barrier injury to the oesophagus can be objectively measured using CT scan.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17205279     DOI: 10.1007/s00520-006-0192-9

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  10 in total

Review 1.  Impaired gut function as risk factor for invasive candidiasis in neutropenic patients.

Authors:  Nicole M A Blijlevens; J Peter Donnelly; Ben E de Pauw
Journal:  Br J Haematol       Date:  2002-05       Impact factor: 6.998

2.  Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy.

Authors:  Xiong Wei; H Helen Liu; Susan L Tucker; Zhongxing Liao; Chaosu Hu; Radhe Mohan; James D Cox; Ritsuko Komaki
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-07-12       Impact factor: 7.038

3.  Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonography.

Authors:  C Cartoni; F Dragoni; A Micozzi; E Pescarmona; S Mecarocci; P Chirletti; M C Petti; G Meloni; F Mandelli
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

4.  Endoscopic Doppler optical coherence tomography in the human GI tract: initial experience.

Authors:  Victor X D Yang; Shou-Jiang Tang; Maggie L Gordon; Bing Qi; Geoffrey Gardiner; Maria Cirocco; Paul Kortan; Gregory B Haber; Gabor Kandel; I Alex Vitkin; Brian C Wilson; Norman E Marcon
Journal:  Gastrointest Endosc       Date:  2005-06       Impact factor: 9.427

5.  Impact of dysphagia on quality of life after treatment of head-and-neck cancer.

Authors:  Nam P Nguyen; Cheryl Frank; Candace C Moltz; Paul Vos; Herbert J Smith; Ulf Karlsson; Suresh Dutta; Allan Midyett; Jessica Barloon; Sabah Sallah
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-01       Impact factor: 7.038

6.  Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients.

Authors:  N M A Blijlevens; J P Donnelly; B E DePauw
Journal:  Bone Marrow Transplant       Date:  2005-10       Impact factor: 5.483

7.  The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis.

Authors:  Linda S Elting; Catherine Cooksley; Mark Chambers; Scott B Cantor; Ellen Manzullo; Edward B Rubenstein
Journal:  Cancer       Date:  2003-10-01       Impact factor: 6.860

8.  Measuring mucosal damage induced by cytotoxic therapy.

Authors:  N M A Blijlevens; B van't Land; J P Donnelly; L M'Rabet; B E de Pauw
Journal:  Support Care Cancer       Date:  2004-01-30       Impact factor: 3.603

9.  The management of treatment-related esophageal complications in children and adolescents with cancer.

Authors:  Dave R Lal; Hamid R Foroutan; Wendy T Su; Suzanne L Wolden; Farid Boulad; Michael P La Quaglia
Journal:  J Pediatr Surg       Date:  2006-03       Impact factor: 2.545

Review 10.  Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview.

Authors:  N M Blijlevens; J P Donnelly; B E De Pauw
Journal:  Bone Marrow Transplant       Date:  2000-06       Impact factor: 5.483

  10 in total
  2 in total

1.  18F-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation.

Authors:  Fidel J Vos; J Peter Donnelly; Wim J G Oyen; Bart-Jan Kullberg; Chantal P Bleeker-Rovers; Nicole M A Blijlevens
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-24       Impact factor: 9.236

2.  A comparative study of the normal oesophageal wall thickness based on 3-dimensional, 4-dimensional, and cone beam computed tomography.

Authors:  Chao Yue Hu; Yan Kang Li; Jian Bin Li; Jin Zhi Wang; Qian Shao; Wei Wang; Yan Luan Guo; Min Xu; Wen Wu Li
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.